MEF2 transcription factors regulate distinct gene programs in mammalian skeletal muscle differentiation

Journal of Biological Chemistry

Volumn 290, Issue 2, 2015, Pages 1256-1268

  Estrella, Nelsa L ^a   Desjardins, Cody A ^a   Nocco, Sarah E ^a   Clark, Amanda L ^a   Maksimenko, Yevgeniy ^a   Naya, Francisco J ^a  

^a USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C (PROGRAMMING LANGUAGE); GENES; MAMMALS; MUSCLE; MUSCULOSKELETAL SYSTEM; TRANSCRIPTION FACTORS;

CELL TYPES; MYOBLASTS; NONOVERLAPPING; REGULATED GENES; SKELETAL MUSCLE; SKELETAL MUSCLE DIFFERENTIATION; TRANSCRIPTIONAL FUNCTIONS; TRANSCRIPTIONAL REGULATION;

TRANSCRIPTION;

MYOCYTE ENHANCER FACTOR 2; MYOCYTE ENHANCER FACTOR 2A; MYOCYTE ENHANCER FACTOR 2B; MYOCYTE ENHANCER FACTOR 2C; MYOCYTE ENHANCER FACTOR 2D; UNCLASSIFIED DRUG; ISOPROTEIN;

ADULT; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE; GENE CONTROL; GENE SILENCING; GENOME; MEF2A GENE; MEF2B GENE; MEF2C GENE; MEF2D GENE; MOUSE; MUSCLE DEVELOPMENT; MUSCLE METABOLISM; MYOBLAST; MYOPATHY; NONHUMAN; OVERLAPPING GENE; PROTEIN FUNCTION; SKELETAL MUSCLE; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; CYTOLOGY; DROSOPHILA; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; MAMMAL; METABOLISM; MOLECULAR EVOLUTION;

MAMMALIA; VERTEBRATA;

ANIMALS; CELL DIFFERENTIATION; CERCOPITHECUS AETHIOPS; COS CELLS; DROSOPHILA; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MAMMALS; MEF2 TRANSCRIPTION FACTORS; MICE; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOBLASTS; PROTEIN ISOFORMS;

EID: 84920972839     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.589838     Document Type: Article

References (48)

1. Buckingham, M., and Rigby, P. W. (2014) Gene regulatory networks and transcriptional mechanisms that control myogenesis. Dev. Cell 28, 225-238
2. Braun, T., and Gautel, M. (2011) Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis. Nat. Rev. Mol. Cell Biol. 12, 349-361
3. Black, B. L., and Olson, E. N. (1998) Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14, 167-196
4. Potthoff, M. J., and Olson, E. N. (2007) MEF2: a central regulator of diverse developmental programs. Development. 134, 4131-4140
5. Sandmann, T., Jensen, L. J., Jakobsen, J. S., Karzynski, M. M., Eichenlaub, M. P., Bork, P., and Furlong, E. E. (2006) A temporal map of transcription factor activity: Mef2 directly regulates target genes at all stages of muscle development. Dev. Cell 10, 797-807
6. Edmondson, D. G., Lyons, G. E., Martin, J. F., and Olson, E. N. (1994) Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development. 120, 1251-1263
7. Zhu, B., Ramachandran, B., and Gulick, T. (2005) Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain. J. Biol. Chem. 280, 28749-28760
8. Sebastian, S., Faralli, H., Yao, Z., Rakopoulos, P., Palii, C., Cao, Y., Singh, K., Liu, Q. C., Chu, A., Aziz, A., Brand, M., Tapscott, S. J., and Dilworth, F. J. (2013) Tissue-specific splicing of a ubiquitously expressed transcription factor is essential for muscle differentiation. Genes Dev. 27, 1247-1259
9. Potthoff, M. J., Arnold, M. A., McAnally, J., Richardson, J. A., Bassel-Duby, R., and Olson, E. N. (2007) Regulation of skeletal muscle sarcomere integrity and postnatal muscle function by Mef2c. Mol. Cell Biol. 27, 8143-8151
10. Potthoff, M. J., Wu, H., Arnold, M. A., Shelton, J. M., Backs, J., McAnally, J., Richardson, J. A., Bassel-Duby, R., and Olson, E. N. (2007) Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J. Clin. Invest. 117, 2459-2467
11. Snyder C. M., Rice, A. L., Estrella, N. L., Held, A., Kandarian, S. C., and Naya, F. J. (2013) MEF2A regulates the Gtl2-Dio3 microRNA mega-cluster to modulate WNT signaling in skeletal muscle regeneration. Development 140, 31-42
12. Seok, H. Y., Tatsuguchi, M., Callis, T. E., He, A., Pu, W. T., and Wang, D. Z. (2011) miR-155 inhibits expression of the MEF2A protein to repress skeletal muscle differentiation. J. Biol. Chem. 286, 35339-35346
13. Liu, N., Nelson, B. R., Bezprozvannaya, S., Shelton, J. M., Richardson, J. A., Bassel-Duby, R., and Olson, E. N. (2014) Requirement of MEF2A, C, andD for skeletal muscle regeneration. Proc. Natl. Acad. Sci. U.S.A. 111, 4109-4114
14. McCalmon, S. A., Desjardins, D. M., Ahmad, S., Davidoff, K. S., Snyder, C. M., Sato, K., Ohashi, K., Kielbasa, O. M., Mathew, M., Ewen, E. P., Walsh, K., Gavras, H., and Naya, F. J. (2010) Modulation of angiotensin II mediated cardiac remodeling by the MEF2A target gene Xirp2. Circ. Res. 106, 952-960
15. Ewen, E. P., Snyder, C. M., Wilson, M., Desjardins, D., and Naya, F. J. (2011) The Mef2A transcription factor coordinately regulates a costamere gene program in cardiac muscle. J. Biol. Chem. 286, 29644-29653
16. Huang, D. W., Sherman, B. T., and Lempicki, R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57
17. Huang, D. W., Sherman, B. T., and Lempicki, R. A. (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13
18. Grant, C. E., Bailey, T. L., and Noble, W. S. (2011) FIMO: scanning for occurrences of a given motif. Bioinformatics. 27, 1017-1018
19. Crooks, G. E., Hon, G., Chandonia, J.-M., and Brenner, S. E. (2004) WebLogo: a sequence logo generator. Genome Res. 14, 1188-1190
20. Quandt, K., Frech, K., Karas, H., Wingender, E., and Werner, T. (1995) MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23, 4878-4884
21. Ramachandran, B., Yu, G., Li, S., Zhu, B., and Gulick, T. (2008) Myocyte enhancer factor 2A is transcriptionally autoregulated. J. Biol. Chem. 283, 10318-10329
22. Xu, J., Gong, N. L., Bodi, I., Aronow, B. J., Backx, P. H., and Molkentin, J. D. (2006) Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice. J. Biol. Chem. 281, 9152-9162
23. Buettner, F. F., Ashikov, A., Tiemann, B., Lehle, L., and Bakker, H. (2013) C. elegans DPY-19 is a C-mannosyltransferase glycosylating thrombospondin repeats. Mol. Cell 50, 295-302
24. Watanabe, K., Takebayashi, H., Bepari, A. K., Esumi, S., Yanagawa, Y., and Tamamaki, N. (2011) Dpy19l1, a multi-transmembrane protein, regulates the radial migration of glutamatergic neurons in the developing cerebral cortex. Development 138, 4979-4990
25. Bendall, A. J., and Abate-Shen, C. (2000) Roles for Msx and Dlx homeoproteins in vertebrate development. Gene 247, 17-31
26. Mayer, U. (2003) Integrins: redundant or important players in skeletal muscle? J. Biol. Chem. 278, 14587-14590
27. Sorimachi, H., and Ono, Y. (2012) Regulation and physiological roles of the calpain system in muscular disorders. Cardiovasc. Res. 96, 11-22
28. Messina, D. N., Glasscock, J., Gish, W., and Lovett, M. (2004) An ORFeome-based analysis of human transcription factor genes and the construction of a microarray to interrogate their expression. Genome Res. 14, 2041-2047
29. Liu, J., and Stormo, G. D. (2008) Context-dependent DNA recognition code for C2H2 zinc-finger transcription factors. Bioinformatics 24, 1850-1857
30. Svingen, T., and Tonissen, K. F. (2006) Hox transcription factors and their elusive mammalian gene targets. Heredity 97, 88-96
31. Berry, F. B., Miura, Y., Mihara, K., Kaspar, P., Sakata, N., Hashimoto- Tamaoki, T., and Tamaoki, T. (2001) Positive and negative regulation of myogenic differentiation of C2C12 cells by isoforms of the multiple homeodomain zinc finger transcription factor ATBF1. J. Biol. Chem. 276, 25057-25065
32. Heidt, A. B., Rojas, A., Harris, I. S., and Black, B. L. (2007) Determinants of myogenic specificity within MyoD are required for noncanonical E box binding. Mol. Cell. Biol. 27, 5910-5920
33. Grade, C. V., Salerno, M. S., Schubert, F. R., Dietrich, S., and Alvares, L. E. (2009) An evolutionarily conserved Myostatin proximal promoter/enhancer confers basal levels of transcription and spatial specificity in vivo. Dev. Genes Evol. 219, 497-508
34. Knoepfler, P. S., Bergstrom, D. A., Uetsuki, T., Dac-Korytko, I., Sun, Y. H., Wright, W. E., Tapscott, S. J., and Kamps, M. P. (1999) A conserved motif N-terminal to the DNA-binding domain of myogenic bHLH transcription factors mediates cooperative DNA binding with Pbx-Meis1/Prep1. Nucleic Acids Res. 27, 3752-3761
35. Imoto, I., Sonoda, I., Yuki, Y., and Inazawa, J. (2001) Identification and characterization of human PKNOX2, a novel homeobox-containing gene. Biochem. Biophys. Res. Commun. 287, 270-276
36. O'Mahoney, J. V., Guven, K. L., Lin, J., Joya, J. E., Robinson, C. S., Wade, R. P., and Hardeman, E. C. (1998) Identification of a novel slow-musclefiber enhancer binding protein, MusTRD1. Mol. Cell Biol. 18, 6641-6652
37. Tassabehji, M., Carette, M., Wilmot, C., Donnai, D., Read, A. P., and Metcalfe, K. (1999) A transcription factor involved in skeletal muscle gene expression is deleted in patients with Williams syndrome. Eur. J. Hum. Genet. 7, 737-747
38. Ornatsky, O. I., Andreucci, J. J., and McDermott, J. C. (1997) A dominantnegative form of transcription factor MEF2 inhibits myogenesis. J. Biol. Chem. 272, 33271-33278
39. Paris, J., Virtanen, C., Lu, Z., and Takahashi, M. (2004) Identification of MEF2-regulated genes during muscle differentiation. Physiol. Genomics 20, 143-151
40. Blais, A., Tsikitis, M., Acosta-Alvear, D., Sharan, R., Kluger, Y., and Dynlacht, B. D. (2005) An initial blueprint for myogenic differentiation. Genes Dev. 19, 553-569
41. Wales, S., Hashemi, S., Blais, A., and McDermott, J. C. (2015) Global MEF2 target gene analysis in cardiac and skeletal muscle revealsnovel regulation of DUSP6 by p38MAPK-MEF2 signaling. Nucleic Acids Res. 42, 11349-11362
42. Megeney, L. A., Kablar, B., Garrett, K., Anderson, J. E., and Rudnicki, M. A. (1996) MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev. 10, 1173-1183
43. Doherty, K. R., Cave, A., Davis, D. B., Delmonte, A. J., Posey, A., Earley, J. U., Hadhazy, M., and McNally, E. M. (2005) Normal myoblast fusion requires myoferlin. Development 132, 5565-5575
44. Nguyen, N. U., Liang, V. R., and Wang, H.-V. (2014) Actin-associated protein palladin is required for migration behavior and differentiation potential of C2C12 myoblast cells. Biochem. Biophys. Res. Commun. 452, 728-733
45. George, B., Jain, N., Fen Chong, P., Hou Tan, J., and Thanabalu, T. (2014) Myogenesis defect due to Toca-1 knockdown can be suppressed by expression of N-WASP. Biochim. Biophys. Acta 1843, 1930-1941
46. Estrella, N. L., and Naya, F. J. (2014) Transcriptional networks regulating the costamere, sarcomere, and other cytoskeletal structures in striated muscle. Cell Mol. Life Sci. 71, 1641-1656
47. Molkentin, J. D., and Olson, E. N. (1996) Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc. Natl. Acad. Sci. U.S.A. 93, 9366-9373
48. Cao, Y., Yao, Z., Sarkar, D., Lawrence, M., Sanchez, G. J., Parker, M. H., MacQuarrie, K. L., Davison, J., Morgan, M. T., Ruzzo, W. L., Gentleman, R. C., and Tapscott, S. J. (2010) Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming. Dev. Cell 18, 662-674